tiprankstipranks

David Moss Insider Profile

4 Followers
David Moss, PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner at Tonix Pharma, holds 1.27M shares in Inmune Bio (Ticker: INMB), holds 3.25M shares in Tonix Pharma (Ticker: TNXP).
tipranks
David Moss

David Moss
Tonix Pharma (TNXP)
PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner

Ranked #21,015 out of 98,042 Corporate Insiders

Profitable Transactions

60%
3 out of 5 Profitable Transactions

Average Return

+13.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$12M
84.92%
15.08%
A breakdown of David Moss's holdings

Insider Roles

Inmune Bio
(INMB)
CFO, Ten Percent Owner
Tonix Pharma
(TNXP)
PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner
Roles that David Moss holds in companies

Most Profitable Insider Trade

Stock:
Inmune Bio
(INMB)
Rating:Informative Buy
Date:Mar 20, 2023 - Mar 20, 2024
Return:+86.90%
The most profitable trade made by David Moss

David Moss's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tonix Pharma
May 05, 2011
PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner
Informative Buy
10.00K
$1.82M
Inmune Bio
Apr 23, 2024
CFO, Ten Percent Owner
Uninformative Buy
149.99K
$10.25M
List of latest transactions for each holding click on a transaction to see David Moss's performance on stock

David Moss insider profile FAQ

What is the percentage of profitable transactions made by David Moss?
The percentage of profitable transactions made by David Moss is 60%.
    What is the average return per transaction made by David Moss?
    The average return per transaction made by David Moss is 13.40%.
      What stocks does David Moss hold?
      David Moss holds: TNXP, INMB stocks.
        What was David Moss’s latest transaction?
        David Moss latest transaction was an Uninformative Buy of $149.99K.
          What was David Moss's most profitable transaction?
          David Moss’s most profitable transaction was an Informative Buy of INMB stock on March 20, 2023. The return on the trade was 86.90%.
            What is David Moss's role in Tonix Pharma?
            David Moss's role in Tonix Pharma is PRES, CEO, TRES, CFO, SECR, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.